Unusual epidemic events: A new method of early orientation and differentiation between natural and deliberate epidemics

Public Health

Volumn 126, Issue 1, 2012, Pages 77-81

  Radosavljevic, V ^a,b   Belojevic, G ^c  

^a MILITARY ACADEMY   (Serbia)

^b Army of Serbia   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Biological warfare; Disease outbreaks; Scoring methods

Indexed keywords

BIOTERRORISM; DISEASE PREVALENCE; EPIDEMIC; NUMERICAL MODEL; PATHOGEN; PUBLIC HEALTH; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

ARTICLE; BIOLOGICAL WARFARE; CLINICAL INDICATOR; CONTROLLED STUDY; DELIBERATE EPIDEMIC; ENDEMIC DISEASE; EPIDEMIC; HUMAN; INTERMETHOD COMPARISON; NATURAL EPIDEMIC; ORIENTATION; PUBLIC HEALTH; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; SWINE INFLUENZA; TULAREMIA;

ANTHRAX; BIOTERRORISM; EPIDEMICS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; RESEARCH DESIGN; RISK ASSESSMENT; TULAREMIA;

SUIDAE;

EID: 84155167211     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2011.11.006     Document Type: Article

References (26)

1. Schultz C.H. Chinese curses, anthrax, and the risk of bioterrorism. Ann Emerg Med 2004, 43:329-332.
2. Chang M., Glynn M.K., Groseclose S.L. Endemic, notifiable bioterrorism-related diseases, United States, 1992-1999. Emerg Infect Dis 2003, 9:556-564.
3. Grunow R., Finke E.J. A procedure for differentiating between the intentional release of biological warfare agents and natural outbreaks of disease: its use in analyzing the tularemia outbreak in Kosovo in 1999 and 2000. Clin Microbiol Infect 2002, 8:510-521.
4. Dembek Z.F., Kortepeter M.G., Pavlin J.A. Discernment between deliberate and natural infectious disease outbreaks. Epidemiol Infect 2007, 135:353-371.
5. Radosavljević V., Belojević G. A new model of bioterrorism risk assessment. Biosecur Bioterror 2009, 7:443-451.
6. Egan J.R., Legrand J., Hall I.M., Cauchemez S., Ferguson N.M., Leach S. Re-assessment of mitigation strategies for deliberate releases of anthrax using a real-time outbreak characterization tool. Epidemics 2010, 2:189-194.
7. Doroshenko A., Cooper D., Smith G., Gerard E., Chinemana F., Verlander N., et al. Evaluation of syndromic surveillance based on national health service direct derived data - England and Wales. MMWR 2005, 54(Suppl):117-122.
8. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
9. Chang L.Y., Shih S.R., Shao P.L., Tsung-Ning Huang D., Huang L.M. Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st Century. J Formos Med Assoc 2009, 108:526-532.
10. Tuite A.R., Greer A.L., Whelan M., Winter A.-L., Lee B., Yan P., et al. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ 2010, 182:131-136.
11. Petrosillo N., Di Bella S., Drapeau C.M., Grilli E. The novel influenza A (H1N1) virus pandemic: an update. Ann Thorac Med 2009, 4:163-172.
12. World Health Organization. Pandemic (H1N1) 2009 - update 60. World Health Organization, Geneva, Switzerland, 2009. Available at: (last accessed on 12/08/2009). http://www.who.int/csr/don/2009_08_04/en/index.html.
13. Department of Health. Swine flu: UK planning assumptions. Department of Health, London, 2009. Available at: (last accessed 12/08/2009). http://www.dh.gov.uk/en/Publicationsandstatistics/publications/PublicationsPolicyAndGuidance/DH_102892.
14. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 2009, 58:521-524. Centers for Disease Control and Prevention.
15. Gatherer D. The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol 2009, 45:174-178.
16. Novel influenza A (H1N1) investigation team. Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. Euro Surveill 2009; 14: 19295.
17. Williams R.J., Cox N.J., Regnery H.L., Noah D.L., Khan A.S., Miller J.M., et al. Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. Milit Med 1997, 162:82-86.
18. Grayson M.L., Melvani S., Druce J., Barr I.G., Ballard S.A., Johnson P.D.R. Efficacy and soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hand of human volunteers. Clin Infect Dis 2009, 48:285-291.
19. Komiya N., Gu Y., Kamiya H., Yahata Y., Matsui T., Yasui Y., et al. Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009. Euro Surveill 2009, 14:19272.
20. Influenza A(H1N1) investigation teams, Levy-Bruhl D., Vaux S. Modified surveillance of influenza A(H1N1) virus infections in France. Euro Surveill 2009, 14:19276.
21. Gutiιrrez I., Litzroth A., Hammadi S., Van Oyen H., Gerard C., Robesyn E., et al. Community transmission of influenza A (H1N1)v virus at a rock festival in Belgium, 2-5 July 2009. Euro Surveill 2009, 14:19294.
22. Reintjes R., Dedushaj I., Gjini A., Jorgensen T.R., Cotter B., Lieftucht A., et al. Tularemia outbreak investigation in Kosovo: case-control and environmental studies. Emerg Infect Dis 2002, 8:69-73.
23. Woods C.W., Ospanov K., Myrzabekov A., Favorov M., Plikaytis B., Ashford D.A. Risk factors for human anthrax among contacts of anthrax-infected livestock in Kazakhstan. Am J Trop Med Hyg 2004, 71:48-52.
24. Marshall E. Sverdlovsk: anthrax capital?. Science 1988, 240:383-385.
25. Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Shelokov A. The Sverdlovsk anthrax outbreak of 1979. Science 1994, 266:1202-1208.
26. Leitenberg M. The problem of biological weapons. Stockholm: Swedish National Defence College 2004, pp. 25-48.